INSTITUTO BUTANTAN - ADALIMUMABE 40 MG SOL INJ CT BL PLAS X 2 SER VD PREENCH C/ AGU X 0,4 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1223400500067 -
GGREM
545325090004807 -
Código de barras
7897965403020
O que a fonte publica
- Detentor do registro
- INSTITUTO BUTANTAN
- Princípios ativos
- ADALIMUMABE
- Embalagem
- 40 MG SOL INJ CT BL PLAS X 2 SER VD PREENCH C/ AGU X 0,4 ML
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
Nomes pelos quais este registro é encontrado
- INSTITUTO BUTANTAN - ADALIMUMABE 40 MG SOL INJ CT BL PLAS X 2 SER VD PREENCH C/ AGU X 0,4 ML
- INSTITUTO BUTANTAN - ADALIMUMABE
- ADALIMUMABE
Dados completos da fonte
{
"name": "INSTITUTO BUTANTAN - ADALIMUMABE 40 MG SOL INJ CT BL PLAS X 2 SER VD PREENCH C/ AGU X 0,4 ML",
"holder": "INSTITUTO BUTANTAN",
"stripe": null,
"barcodes": [
"7897965403020"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "545325090004807",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.821.344/0001-56",
"priceRegime": "Regulado",
"productName": "INSTITUTO BUTANTAN - ADALIMUMABE",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "40 MG SOL INJ CT BL PLAS X 2 SER VD PREENCH C/ AGU X 0,4 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "9696.95",
"icms-12": "11019.26",
"icms-17": "11683.07",
"icms-18": "11825.55",
"icms-19": "11971.54",
"icms-20": "12121.19",
"icms-21": "12274.62",
"icms-22": "12431.98",
"icms-23": "12593.44",
"icms-17.5": "11753.88",
"icms-19.5": "12045.90",
"icms-20.5": "12197.42",
"icms-22.5": "12512.20",
"icms-12-alc": "10887.03",
"icms-17-alc": "11542.87",
"icms-18-alc": "11683.64",
"icms-19-alc": "11827.88",
"icms-20-alc": "11975.72",
"icms-21-alc": "12127.33",
"icms-22-alc": "12282.80",
"icms-23-alc": "12442.31",
"withoutTaxes": "9580.59",
"icms-17.5-alc": "11612.82",
"icms-19.5-alc": "11901.35",
"icms-20.5-alc": "12051.05",
"icms-22.5-alc": "12362.05"
},
"pisCofinsList": "Positiva",
"substanceText": "ADALIMUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "13366.24",
"icms-12": "15188.90",
"icms-17": "16103.90",
"icms-18": "16300.29",
"icms-19": "16501.52",
"icms-20": "16707.80",
"icms-21": "16919.29",
"icms-22": "17136.19",
"icms-23": "17358.75",
"icms-17.5": "16201.50",
"icms-19.5": "16604.02",
"icms-20.5": "16812.87",
"icms-22.5": "17246.76",
"icms-12-alc": "15050.68",
"icms-17-alc": "15957.34",
"icms-18-alc": "16151.95",
"icms-19-alc": "16351.35",
"icms-20-alc": "16555.73",
"icms-21-alc": "16765.32",
"icms-22-alc": "16980.25",
"icms-23-alc": "17200.76",
"withoutTaxes": "13244.60",
"icms-17.5-alc": "16054.04",
"icms-19.5-alc": "16452.92",
"icms-20.5-alc": "16659.87",
"icms-22.5-alc": "17089.81"
},
"invalidBarcodes": [],
"activeSubstances": [
"ADALIMUMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1223400500067",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:545325090004807"